Xenical Rx-To-OTC Switch Filing Slated For 2005
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline will file for an Rx-to-OTC switch of Xenical (orlistat) a year earlier than expected
You may also be interested in...
Xenical Off-The-Market Switch Sought By Public Citizen
Public Citizen is calling for prescription weight-loss drug Xenical (120 mg orlistat) to be pulled from the market days after FDA issued an "approvable" letter for an OTC version
Xenical Adolescent Safety, Efficacy Needs Further Study – JAMA Editorial
More research is needed on Xenical (orlistat) therapy for adolescent weight loss, according to an editorial in the June 15 Journal of the American Medical Association
Xenical Pediatric AERs Need Continued Monitoring, FDA Says
Pediatric adverse events associated with Roche's Xenical (orlistat) could be a concern for FDA when an attempt is made to switch the drug over the counter